Clinical Evidence
Comparison of a Computer-Based Intravenous Insulin Program with a Standard Paper Protocol in Terms of Safety and Efficacy in Management of DKA Patients in Community Hospitals: A Pilot Study
Setting: Cohort of six community hospitals.
Objective
This retrospective analysis compares safety and efficacy of a standard paper protocol to a computer-based glucose management system (EndoTool) for patients admitted with diabetic ketoacidosis (DKA).
Setting
Cohort of six community hospitals.
Results
- Mean time to a blood glucose <200 mg/dL was 287 minutes with EndoTool versus 336 minutes with a paper protocol.
- Incidence of hypoglycemia was 0.00% of patients with EndoTool versus 10.0% of patients with a paper protocol.
- Mean number of finger stick blood glucose readings per hour was 0.91 with EndoTool versus 0.99 with a paper protocol.
- Nursing adherence to dosing recommendations was 100% with EndoTool versus 37% with a paper protocol.
Conclusions
With faster time to control, lower incidence of hypoglycemia and fewer finger sticks, a computer-based glucose management system (EndoTool) provides a safer, more simplified approach to intravenous insulin therapy than a paper protocol for patients admitted with DKA.
References
Authors
M. Raihan Azad; Sandra Hardee; Su-Fan Vanessa Lin; Robert Tanenberg.
Source
Presented at American Association of Clinical Endocrinologists Scientific & Clinical Congress.
Year
2017
Related posts
Clinical Evidence
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Clinical Evidence
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
20 minute read
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields